Salix Pharmaceuticals Ltd (SLXP) Tops Q4 EPS by 13c; Issues Confident FY14 Outlok
Tweet Send to a Friend
Salix Pharmaceuticals Ltd (NASDAQ: SLXP) reported Q4 EPS of $1.06, $0.13 better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
